Ortega-Franco, Ana http://orcid.org/0000-0002-2865-1855
Hodgson, Clare
Raja, Haseem
Carter, Mathew
Lindsay, Colin
Hughes, Sarah
Cove-Smith, Laura
Taylor, Paul
Summers, Yvonne
Blackhall, Fiona http://orcid.org/0000-0001-8716-3395
Califano, Raffaele http://orcid.org/0000-0003-2611-5319
Article History
Accepted: 5 May 2022
First Online: 4 July 2022
Declarations
:
: No external funding was used in the preparation of this manuscript.
: F.B has received honoraria and consultancy fees from AstraZeneca, Jansen, Pfizer, Bayer, Roche Genentech, MSD. R.C has received honoraria and consultancy fees from MSD, AstraZeneca, Roche and Bristol Myers Squibb. Y.S is a member of the advisory board for MSD. A.O-F, C.H, H.R, C.L-S, M.C, P.T and S.H declare that they have no conflicts of interest that might be relevant to the contents of this manuscript.
: This study was approved by the ‘Quality Improvement and Clinical Audit’ committee at The Christie.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: A.O-F: Conceptualization, Methodology, Formal analysis, Data Curation, Writing - Original Draft, Visualization. C.H: Methodology, Formal analysis. Writing - Review & Editing, Visualization. Haseem Raja: Data Curation, Visualization. R.C: Conceptualization, Methodology, Writing - Review & Editing, Supervision. C.L, F.B, L.C-S, M.C, P.T, S.H, Y.S: Writing - Review & Editing.